Anti-KAAG1 (ADCT-901-MMAE)
Anti-KAAG1 (ADCT-901-MMAE) is an ADC composed of a humanized monoclonal antibody (3A4) targeting human KAAG1. It is used for the treatment of advanced solid tumors including platinum resistant ovarian cancer and triple negative breast cancer. MW :145.28 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A3153 |
Sku # | A3153-1mg*25 |
Pricing | 1mg*25, $5070.00 |